黄连肉桂药对配伍研究

目的:黄连和肉桂是古方交泰丸治疗心肾不交型失眠的主要组成药物,确定黄连、肉桂药对配伍的单煎合并或合煎的提取方法,以及含量测定的方法。方法:采用水煎煮法考察挥发油的最佳提取工艺,通过紫外可见分光光度法确定黄连、肉桂配伍的总生物碱含量测定的方法;通过高效液相色谱法确定黄连、肉桂配伍的有效成分含量测定的方法。结果:黄连肉桂两味药配伍以后的分煎合并溶液中总生物碱含量比黄连肉桂两味药配伍以后的合煎溶液中总生物碱含量要高;黄连肉桂两味药配伍以后的分煎合并溶液中的有效成分(包括盐酸小檗碱、盐酸药根碱、盐酸巴马汀、桂皮醛、桂皮酸)比黄连肉桂两味药配伍以后的合煎溶液中的有效成分(包括盐酸小檗碱、盐酸药根碱、盐酸巴马汀、桂皮醛、桂皮酸)要高。结论:水煎煮法是挥发油的最佳提取方法。     

交泰丸交通心肾治疗失眠作用机理研究

目的:观察交泰丸及不同拆方对HPA轴调节因子及相关中枢神经递质的影响。方法:将交泰丸分为泻心组(单用黄连)、补肾组(单用肉桂)及交通心肾组(交泰丸),观察各实验组对PCPA大鼠模型失眠状态、HPA轴调节因子CRH、ATCH、CORT及下丘脑相关神经递质5-HT、NE的影响,采用高效液相-库伦阵列电化学检测及放免法检测。结果:PCPA失眠模型大鼠HPA轴呈亢奋状态,下丘脑5-HT含量显著降低,NE的含量有所升高。交泰丸可以通过抑制HPA轴,明显增加失眠大鼠下丘脑5-HT的含量,降低NE的含量。结论:交泰丸是通过调节HPA轴达到交通心肾治疗失眠的目的。     

交泰丸不同配伍比例镇静安神作用研究

目的 :寻找交泰丸镇静安神作用的最佳配伍比例。方法 :通过对戊巴比妥钠的协同作用、对小鼠自发活动的影响、对中枢神经递质的影响三个方面 ,进行深入的药理学研究 ,探讨交泰丸不同配伍比例的镇静安神作用。结果 :交泰丸以原方用药黄连与肉桂 10∶ 1比例作用最好。结论 :交泰丸组方配伍是合理的。     

交泰丸对PCPA大鼠大脑中逢核5-HT的影响

目的探讨交泰丸镇静催眠的作用机理。方法选择SD大鼠30只,随机分为正常组、模型组、交泰丸组,采用对氯苯丙氨酸(PCPA)失眠模型,以高效液相检测大脑中逢核五羟色氨(5-HT)含量变化。结论交泰丸可提高模型大鼠大脑中逢核五羟色氨(5-HT)含量,发挥镇静催眠作用。     

交泰丸交通心肾治疗失眠作用机理研究

目的：观察交泰丸及不同拆方对HPA轴调节因子及相关中枢神经递质的影响。方法：将交泰丸分为泻心组（单用黄连）、补肾组（单用肉桂）及交通心肾组（交泰丸）,观察各实验组对PCPA大鼠模型失眠状态、HPA轴调节因子C1LH、ATCH、COKT及下丘脑相关神经递质5-HT、NE的影响,采用高效液相一库伦阵列电化学检测及放免法检测。结果：PCPA失眠模型大鼠HPA轴呈亢奋状态,下丘脑5-HT含量显著降低,NE的含量有所升高。交泰丸可以通过抑制HPA轴,明显增加失眠大鼠下丘脑5-HT的含量,降低NE的含量。结论：交泰丸是通过调节HPA抽达到交通心肾治疗失眠的目的。     

不同比例配伍对交泰丸有效成分含量变化的影响

目的:建立反相高效液相法测定黄连和肉桂不同比例配伍后的5种有效成分:小檗碱、药根碱、巴马亭、桂皮醛和肉桂酸的质量百分含量变化趋势.方法:采用高效液相色谱法.结果:黄连含量固定随着肉桂配伍含量增加,黄连中的生物碱含量比例下降;随着肉桂含量增加,桂皮醛和肉桂酸含量未呈比例上升.结论:高效液相定量测定药物成分含量方法准确、敏捷、数据可靠为药效学提供了科学定量依据.     

交泰丸治疗2型糖尿病合并失眠的疗效观察

目的评价交泰丸对2型糖尿病伴失眠患者的临床疗效。方法受试对象60例随机分为交泰丸1组(黄连:肉桂=2∶1)、交泰丸2组(黄连:肉桂=10∶1)和对照组,每组各20例,治疗周期为8周,评价交泰丸对受试者血糖水平及失眠的双重改善情况。结果与对照组相比,交泰丸1组具有降低2型糖尿病患者血糖水平及改善口渴症状的作用(P<0.05),而交泰丸2组对失眠、心烦具有更好的疗效(P<0.05)。结论主治心肾不交之经典名方交泰丸对2型糖尿病伴失眠患者具有降血糖及改善失眠的双重疗效。     

交泰丸对睡眠剥夺小鼠视交叉上核生物钟基因Clock及Bmal 1表达的影响

目的观察交泰丸对睡眠剥夺小鼠视交叉上核(SCN)中生物钟基因Clock和Bmal 1表达的影响,探讨交泰丸改善睡眠的可能机制。方法将小鼠随机分为空白组、模型组、百乐眠组和交泰丸组。除空白组外,其他各组腹腔注射氯苯丙氨酸(PCPA)以制备睡眠剥夺模型。用自主活动测试仪记录小鼠自主活动时间,ELISA检测血清中5-HT、Glu、DA、GABA的表达水平,Real time-PCR和免疫组化检测SCN中Clock和Bmal 1的表达。结果与空白组比较,模型组小鼠活动时间显著增加(0.01);与模型组比较,百乐眠组和交泰丸组小鼠活动时间有不同程度减少(0.05)。与空白组比较,模型组小鼠血清中GABA、5-HT含量降低(0.01),Glu含量升高(0.01);与模型组比较,百乐眠组和交泰丸组小鼠血清中GABA、5-HT含量升高(0.01,0.05),Glu含量降低(0.05);各组小鼠血清中DA含量变化不明显,差异没有统计学意义(0.05)。与空白组比较,模型组小鼠SCN中Clock、Bmal1的基因和蛋白表达水平升高(0.01);与模型组比较,百乐眠组和交泰丸组小鼠SCN中Clock、Bmal1的基因和蛋白表达下降(0.01,0.05)。结论交泰丸具有改善睡眠的作用,其机制可能与交泰丸调节小鼠SCN中Clock和Bmal 1的表达有关。     

交泰丸对利血平诱导小鼠抑郁模型的影响

[目的] 探讨交泰丸对利血平诱导小鼠抑郁模型的影响。[方法] 采用小鼠强迫游泳实验（FST）、小鼠悬尾实验（TST）和小鼠利血平拮抗实验,通过高效液相色谱（HPLC）测定小鼠海马和皮质组织中单胺类神经递质[去甲肾上腺素（NE）、5-羟色胺（5-HT）、5-羟吲哚乙酸（5-HIAA）]含量的变化,探讨交泰丸的抗抑郁作用。[结果] 交泰丸组方各剂量组均能明显减少FST和TST的不动时间,并且均能拮抗利血平诱导的小鼠眼睑下垂和体温下降,而且可以逆转NE和5-HT的减少以及降低5-HIAA的含量。[结论] 交泰丸具有明显的抗抑郁作用,并且可以通过调节海马组织和皮质中NE和5-HT的含量而发挥抗抑郁作用。     

巴戟天水提液对自然衰老小鼠脑组织中单胺类神经递质含量的影响

目的 研究巴戟天水提液对自然衰老小鼠脑组织中多巴胺（DA）、去甲肾上腺素（NE）、肾上腺素（E）和5-羟色胺（5-HT）含量的影响,探讨巴戟天益脑的作用机制.方法 17个月龄昆明种小鼠连续给药15天后进行力竭性负重游泳实验,并采用高效液相-库伦阵列（HPLC-ECD）法检测小鼠脑组织中单胺类神经递质含量,比较分析各给药组与空白组的差异.结果 巴戟天水提液能提高小鼠负重游泳时间,与空白组相比,巴戟天水提液高、中、低剂量组脑组织中NE、E、DA的含量均升高,且E和DA的含量存在明显的量效关系,5-HT的含量则降低.结论 巴戟天水提液能明显提高大鼠脑中能提高记忆的NE、E、DA的含量,同时降低能阻抑记忆的5-HT的含量,表明巴戟天水提液可以通过改变脑内单胺类神经递质的含量而益脑.     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…